BMI Alone Misses Obesity in Up to 8.6% of Adults, an 844,000-Person Nature Study Finds
A Nature analysis across China, the UK, the US and Spain says adding waist measures corrects BMI errors and that clinical obesity carries a much higher death risk than preclinical.
Friday, November 13, 2026/2 min read
Body mass index, the height-and-weight ratio that has defined obesity for decades, gets both calls wrong for a measurable slice of adults. A study of 844,108 people in China, the UK, the US and Spain, reported in Nature this week, found that BMI alone missed obesity-level body fat in up to 8.6% of participants and wrongly labelled up to 3.1% as having obesity, according to Euronews.
The paper, "Validation of clinical and preclinical obesity across global cohorts", is led by Huazhong University of Science and Technology and includes Prof Francesco Rubino of King's College London as senior author. It tests a framework proposed in a January 2025 Lancet Diabetes and Endocrinology commission, and News-Medical's summary sets out the design in detail.
What did the study find about BMI and obesity?
The cohorts were the Kailuan Study in China (137,795 adults), UK Biobank (436,203), the US All of Us programme (218,841) and the Spanish SIDIAP primary-care database (51,269), all aged 18 to 74 with no earlier stroke, heart attack or cancer. News-Medical reports that BMI-only classification overestimated obesity in 1.2% to 3.1% of participants and underestimated it in 5.2% to 8.6%.
Adding waist circumference and waist-to-height ratio raised the measured prevalence of obesity by 3.5 percentage points in China, 3.3 in the UK, 5.6 in the US and 7.4 in Spain, bringing it to 21.3%, 27.3%, 48.1% and 26.1% respectively. A single waist-to-height cut-off of 0.50 flagged many more people, but those picked up only by it did not show higher mortality risk, and ethnicity-specific thresholds worked better.
What is the difference between clinical and preclinical obesity?
Clinical obesity, in the framework, means excess body fat plus at least one sign that organs or daily function are impaired. Preclinical obesity means excess fat with function preserved. Clinical obesity made up 22.7% to 31.3% of obesity cases, or 5.6% to 10.9% of the adult population, depending on the cohort.
The mortality gap is the study's central argument. Per News-Medical, clinical obesity carried a 69% higher hazard of death from any cause than having neither obesity nor organ dysfunction, against 19% for preclinical obesity. Overweight or obesity by BMI alone, without the extra measures, was not tied to higher all-cause mortality. Euronews adds that between 77% and 91% of people with preclinical obesity did not progress to clinical obesity over ten years.
What does this change for patients and treatment?
Rubino said, in the Euronews report, that people with obesity deserve care matched to their needs, no less and no more. The authors argue for preventive care in preclinical obesity and more intensive management once organ function is affected, and say preclinical obesity should not automatically rule out active treatment.
The study has limits its authors state plainly: it is retrospective, relies on health records, uses organ-dysfunction indicators that differed between datasets, and cannot attribute dysfunction to obesity in an individual patient. They call for prospective studies in more diverse populations.
This article is reporting, not medical advice. Questions about weight, measurements or treatment, including weight-loss medication, belong with a clinician who knows your history, and nothing here should change a treatment plan without that conversation.
The next test is whether health systems and insurers adopt measures beyond BMI, a decision that will rest on the prospective evidence the authors say is still needed.
Published in The Outspoken Digest
Editorial desk
Outspoken Digest Health DeskMedicine, public health and the research behind the headlines, read carefully.
Newsletter
The Digest, in your inbox
One edition, sent when it is ready. No noise, and your address is never passed on.
Read Next
More Health →
Microsoft Outage Cuts NHS Email, GP Online Forms and Pharmacy Links, Though Clinical Systems Are Reported Working
Nov 13, 2026/3 min read
WHO Reports 1.13 Million TB Deaths in 2025 as Donor Funding Falls 14 Percent
Nov 12, 2026/2 min read
FDA Approves Sunharbo, the First Factor XIa Inhibitor, to Prevent a Second Stroke at a $748.50 List Price
Nov 12, 2026/2 min read
Sham-Controlled Trial Finds HEPA Air Cleaners in Bedrooms Cut Blood Sugar Swings 8 Percent in Prediabetes
Nov 9, 2026/2 min read